Systemic inaccuracies, proportional to the concentrations of serum proteins
and the thyroxine (T-4) they carry, have been reported in direct free T-4
immunoassays. However, analytical recoveries of free T-4 have not been care
fully examined in most current methods, and they have not previously been e
xamined across the pathophysiological range of serum T-4 binding. In the pr
esent study we investigated ranges of serum T-4 binding using free and tota
l T-4 measurements from 1359 individuals. Carefully characterized, gravimet
rically calibrated, serum-based free T-4 test solutions were then prepared
with a constant normal free T-4 concentration (12 ng/L) and varied serum T-
4 binding (approximately 300:1 to 24,000:1, ng protein bound T-4: ng free T
-4) These standardized test solutions were analyzed using five T-4 analog b
ased free T-4 methods. Analytical recoveries were calculated as ratios of a
ctual free T-4 measurements to the target value, and expressed as a percent
of the target. Analytical recoveries were directly proportional to the ext
ent of serum T-4 binding and ranged 2% to 155%, 25% to 131%, 53% to 106%, 3
7% to 93%, and 37% to 73%, lowest to highest, in different methods. These s
ystemic inaccuracies will confound interpretations of free T-4 test results
in clinical conditions with altered T-4 binding. Future investigations int
o free T-4 status must examine the analytical recovery of the free T-4 meth
od(s) used, as they relate to the extent of serum T-4 binding in the clinic
al condition(s) studied.